イスラエルのトップリンパ腫医師と価格を比較。こちらで最適なマッチングを見つけてください
ご要望と予算に基づいて最適な医師を厳選いたします
医学的監修者 Fahad Mawlood
医学編集者・データサイエンティストトップ医師
25
イスラエル
レビュー
14000+
実際の患者より
個別化された治療計画を無料で取得し、最良のオプションを選択してください。コミットメント不要 · サービス料金なし
最初に表示：
スーラスキー医療センターにおけるリンパ腫の第一人者であり、41年の経験以上の専門的な腫瘍学経験を有する。
, India
Dr. K.K. Iswaran is a reputed and experienced Obstetrician and Gynaecologist with more than 25 years of experience in his field. His key takeaways include:
ロン・ラム医師は、内科、血液学、医療腫瘍学の認定医です。彼のプロフェッショナルな旅は、ニューヨーク州立大学ブルックリン校でのレジデンシーと、ニューヨーク医科大学ウェストチェスター医療センターでの血液学と腫瘍学のフェローシップを含みます。医学分野への彼の献身は、30以上の科学論文と医学教科書の1章を含む広範な学術的貢献を通じて示されています。さらに、彼は数百件の幹細胞移植を行い、この分野での彼の専門性を強調しています。
Ronit El Hasid is the Head of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital. She specializes in bone marrow and umbilical blood transplantation for pediatric patients. Dr. El Hasid has conducted over 300 successful transplantations. This volume of procedures provides her with deep clinical insight into complex hematologic cases.
The doctor treats children with blood disorders and various forms of pediatric cancer. She uses high-precision procedures and therapies to improve patient outcomes. Her clinical focus includes:
Dr. El Hasid treats a wide range of hematologic and oncologic conditions, including:
Dr. El Hasid leads the Department of Pediatric Oncohematology and Oncology at Dana Dwek Children's Hospital. This facility is part of the Sourasky Medical Center (Ichilov) in Tel Aviv. She gained international experience through practice at the City of Hope Hospital in Los Angeles. Additionally, she serves at various medical centers across Israel.
The doctor contributes to the medical community through research and speaking engagements. Her academic record includes:
She stays connected to clinical advancements through several professional organizations:
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Dr. Michael Shapira is an experienced Bone Marrow Transplantation specialist, who speaks English and Hebrew, and graduated from the Hebrew university medical school in 1999.
Dr. Fredi Aviv is an experienced Oncohematologist with 31 years of practice at the Sourasky Medical Center (Ichilov Clinic). Here are the key takeaways about him:
この医師は小児血液学および腫瘍学の分野での第一人者であり、特に小児の血液疾患および骨癌（肉腫）に特化しています。現在、この医師はテルアビブのSourasky Medical Centerの小児血液腫瘍科のディレクターを務め、Dana Children's Hospitalの上級小児科医でもあります。この医師は骨癌および軟部組織肉腫の治療を調整し、血液凝固障害を管理し、早産児の血液学を監督しています。この医師はイスラエル小児血液腫瘍学会（ISPHO）のメンバーです。
この医師はベングリオン大学を卒業し、Kaplan Medical Centerで小児医学を専門とし、Schneider Children's Medical Centerで小児血液学および腫瘍学をさらに専門としました。追加のトレーニングはイタリアのRizzoli Orthopaedic Instituteで骨および軟部組織の腫瘍学において完了しました。
ヤイル博士は血液学の分野、特に慢性リンパ性白血病の治療と研究に重要な貢献をしました。彼の業績は、多くの賞と発表された研究論文によって認められています。
ガル・ゴールドシュタイン博士は、ハダッサ医療センターの小児腫瘍学および血液腫瘍学の高い資格を有する経験豊富な専門家であり、2019-2020年のイスラエルのベストドクターリストにフォーブスにより選ばれ、多くのプロフェッショナル協会のメンバーです。
Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.
He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.
He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.
Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.
He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.
He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).
Oncohematologist
Tamar Jablonski-Perec is an oncologist at the Hadassah Medical Center who received her Doctor of Medical Sciences at the Hebrew University in Jerusalem and completed an internship at the renowned Sloan-Kettering Cancer Center in New York. Her key takeaways include:
Dr. Polina Stepensky is an expert in saving the lives of children, performing over 3,500 bone marrow transplants and being recognized by Forbes as one of the best doctors in 2018. Here are her key takeaways:
ハダサ医療センターの血液学部門の責任者
教授
専門分野
キャリアの初めに、ディナ・ベン・イェフダはネゲブのベン・グリオン大学の医学部に入学しました。
ニューヨークのメモリアル・スローン・ケタリング癌センターで3年間の大学院研修の後、1992年にディナ・ベン・イェフダはハダサに戻りました。
2000年4月には、教授は血液学部門のディレクターに任命されました。
2017年、ベン・イェフダ教授はハダサ医学校の23代目の学部長となり、70年以上の歴史を持つ医療学部を率いる初の女性となりました。
ディナ・ベン・イェフダ教授は、戦闘中に戦死したまたは行方不明となった兵士に関する情報収集の取り組みで、参謀総長賞を受賞した初の女性兵士です。
最近、ディナ・ベン・イェフダはダニエル・ゾンネンフェルド基金から「Heart with the Heart受賞」を受賞しました。この名誉ある賞は、専門の枠を超えて患者に奉仕し、医学倫理以上のことを成し遂げた医師と看護師に与えられます。
専門協会への加入:
イスラエル血液学会
国際血液学会
イスラエル血液腫瘍学会
国際血液腫瘍学会
Professor. Hematology and Transplantology Specialist
25名の医師のうち20名をご覧いただきました
海外のクリニックを選ぶことはストレスフルです。800,000名以上の患者をサポートしたBookimedは、お客様の懸念を理解しています。信頼できる医師、最高の価格品質オプション、複雑なケースの解決策を見つける方法を知っています。すべての段階でお客様をご案内いたします。
ヤン・マツィイフスキー
医療コーディネーターチーム責任者
4300+件以上の患者の旅をガイド
Bookimedで3年
Israelの142名の患者が今月当社を通じて医師を見つけました
2分のクイズ
目標、予算、スケジュールをお聞かせください
人間のマッチング + AI
アルゴリズムがマッチングを見つけ、コーディネーターが適合性を確認します
オプション準備完了
価格、パッケージ、日程を比較。コーディネーターとチャット
選択肢に迷っていますか？
治療をガイド
医療訓練を受けた専属コーディネーター
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 41年の経験 | 複雑なリンパ腫症例 | 高度なリンパ腫治療を専門とし、深い研究との連携を持つ。ESMOファカルティメンバーであり、ソウラスキー医療センター腫瘍科部門の前部門長。 | イスラエル | から $950 |
Top lymphoma specialists in Israel include Dr. Abraham Avigdor, Dr. Ofer Merimsky, and Dr. Avichai Shimoni. These experts hold board certifications in hematology and oncology. Many have completed fellowships at prestigious institutions like MD Anderson and Memorial Sloan-Kettering Cancer Center.
Bookimed Expert Insight: Patients seeking treatment for aggressive lymphoma should target specialists at Sheba Medical Center or Sourasky. These centers house leaders like Dr. Avigdor and Dr. Shimoni, who authored 130+ and 250+ scientific papers respectively. This high research volume often translates to early access to advanced CAR T-cell therapy protocols.
Patient Consensus: Families often feel relieved when finding specialists like Dr. Stepensky, who is known for performng complex pediatric transplants. Many emphasize the importance of choosing doctors trained at major U.S. cancer centers for peace of mind.
Israel has highly specialized pediatric oncohematologists like Dr. Polina Stepensky and Dr. Ronit El Hasid for childhood lymphoma. These specialists work in JCI-accredited centers – the gold standard for hospital safety – and use advanced CAR T-cell therapy and bone marrow transplants to treat young patients.
Bookimed Expert Insight: Israel's pediatric lymphoma infrastructure is unique because top researchers also lead clinical departments. Dr. Abraham Avigdor and Dr. Avichai Shimoni lead national programs while managing CAR T-cell therapy. This means children receive emerging treatments that are often unavailable in general oncology wards elsewhere.
Patient Consensus: Patients emphasize finding a dedicated pediatric hematology-oncology team in a major children's hospital. They highlight the importance of specialists who communicate clearly and move quickly on diagnostic testing.
Israeli lymphoma doctors specialize in CAR-T cell therapy, particularly for refractory and recurrent blood cancers. Experts at JCI-accredited centers like Sourasky Medical Center (Ichilov) perform these advanced treatments. They use modified immune cells to target lymphoma directly, offering options when standard therapies fail.
Bookimed Expert Insight: Israeli specialists often hold triple board certifications in internal medicine, hematology, and oncology. Dr. Ron Ram at Sourasky Medical Center is one such expert. This broad training means they can manage both the lymphoma and any complex side effects from intensive CAR-T therapy.
Patient Consensus: Patients are often surprised by the detailed explanations doctors provide about how modified cells work. Those treated for complex lymphomas noticed that specialists coordiante closely with transplant teams to ensure the best possible timing for treatment.
Choosing the best lymphoma doctor in Israel for a second opinion requires identifying department heads with international fellowships. Look for specialists like Dr. Abraham Avigdor or Dr. Erel Joffe, who hold leadership roles at major centers and have trained at elite institutions like Memorial Sloan Kettering Cancer Center.
Bookimed Expert Insight: Israeli lymphoma specialists often hold dual roles as clinical directors and university professors. This combination is vital for second opinions. For example, Dr. Avichai Shimoni is both a department director and a university chair. This ensures your treatment plan follows the latest evidence-based protocols that general oncologists might not yet use.
Patient Consensus: Patients are often impressed by how senior professors personally review every scan and lab result. Many express relief after getting a clear, detailed explanation of their diagnosis that finally makes sense to them.
Leading specialists for Hodgkin's lymphoma in Israel include Dr. Abraham Avigdor at Sheba Medical Center and Dr. Ofer Merimsky at Sourasky Medical Center. These board-certified hematologists are known for pioneering CAR-T cell therapy and personalized immunotherapy protocols for complex blood cancer cases.
Bookimed Expert Insight: Patients seeking the most advanced salvage therapies should note that Sheba Medical Center was the first in Israel to integrate CAR-T cell protocols. Dr. Abraham Avigdor and Dr. Avichai Shimoni lead a unit performing over 1,000 annual transplants, providing a higher density of procedural experience than most regional centers.
Patient Consensus: Patients receiving treatment for lymphoma often emphasize the value of genetic profiling pipelines at Hadassah and Sourasky. Families also highlight that dedicated pediatric teams at Dana Children’s provide specialized support during bone marrow transplant journeys.